Nav: Home

UK heart failure patients twice as likely to die as their Japanese counterparts

September 11, 2018

Heart failure is common, and becoming more so as populations age. It is the primary diagnosis in more than 80,000 admissions to hospital in the UK; more than 200,000 in Japan; and more than 1 million in the US.

It's thought that cultural differences may have a role in differences in death rates for heart failure around the globe. To look at this in more detail, the researchers compared the death rates of 894 heart failure patients admitted to hospital in the UK with 3781 admitted to hospital in Japan.

To compare patients with a similar severity of heart failure, the researchers looked at the risk factors associated with a heightened risk of death in patients with the condition in previously published studies.

The five factors most strongly associated with the risk of death were systolic blood pressure (the amount of pressure in the arteries when the heart muscle contracts) and levels of sodium, urea (a measure of protein turnover and kidney function) and creatinine (a measure of kidney function) in the blood.

They then compared death rates in hospital, and 1, 3, and 6 months after admission.

Although both UK and Japanese patients were of similar age, UK patients had more severe heart failure, as judged by the five most important risk factors. They were also more likely to have ischaemic heart disease (narrowed arteries) and COPD (chronic lung disease).

UK patients were much more likely to die at all the time points measured than were Japanese patients. Much of this difference could be attributed to British patients being sicker at the time of admission. The threshold for hospital admission in the UK seems to be higher than it is in Japan, note the researchers.

But even after accounting for observed differences in risk, British patients were more than twice as likely to have died at 6 months than patients in Japan.

This is an observational study, and as such, can't establish exactly why British patients fared so much worse than patients in Japan. Differences in the quality of care after discharge, attitudes to medical advice and taking medicines, lifestyle, diet or genes might all have influenced outcomes, suggest the researchers.

"Explaining the differences in outcome among countries, cultures and health services might provide insights that could improve care and outcome and inform healthcare policy decisions," they conclude.
-end-


BMJ

Related Heart Failure Articles:

New hope for treating heart failure
Heart failure patients who are getting by on existing drug therapies can look forward to a far more effective medicine in the next five years or so, thanks to University of Alberta researchers.
Activated T-cells drive post-heart attack heart failure
Chronic inflammation after a heart attack can promote heart failure and death.
ICU care for COPD, heart failure and heart attack may not be better
Does a stay in the intensive care unit give patients a better chance of surviving a chronic obstructive pulmonary disease (COPD) or heart failure flare-up or even a heart attack, compared with care in another type of hospital unit?
Tissue engineering advance reduces heart failure in model of heart attack
Researchers have grown heart tissue by seeding a mix of human cells onto a 1-micron-resolution scaffold made with a 3-D printer.
Smoking may lead to heart failure by thickening the heart wall
Smokers without obvious signs of heart disease were more likely than nonsmokers and former smokers to have thickened heart walls and reduced heart pumping ability.
After the heart attack: Injectable gels could prevent future heart failure (video)
During a heart attack, clots or narrowed arteries block blood flow, harming or killing cells in the heart.
Heart failure after first heart attack may increase cancer risk
People who develop heart failure after their first heart attack have a greater risk of developing cancer when compared to first-time heart attack survivors without heart failure, according to a study today in the Journal of the American College of Cardiology.
Scientists use 'virtual heart' to model heart failure
A team of researchers have created a detailed computational model of the electrophysiology of congestive heart failure, a leading cause of death.
Increase in biomarker linked with increased risk of heart disease, heart failure, death
In a study published online by JAMA Cardiology, Elizabeth Selvin, Ph.D., M.P.H., of the Johns Hopkins Bloomberg School of Public Health, Baltimore, and colleagues examined the association of six-year change in high-sensitivity cardiac troponin T with incident coronary heart disease, heart failure and all-cause mortality.
1 in 4 patients develop heart failure within 4 years of first heart attack
One in four patients develop heart failure within four years of a first heart attack, according to a study in nearly 25,000 patients presented today at Heart Failure 2016 and the 3rd World Congress on Acute Heart Failure by Dr.

Related Heart Failure Reading:

Best Science Podcasts 2019

We have hand picked the best science podcasts for 2019. Sit back and enjoy new science podcasts updated daily from your favorite science news services and scientists.
Now Playing: TED Radio Hour

Digital Manipulation
Technology has reshaped our lives in amazing ways. But at what cost? This hour, TED speakers reveal how what we see, read, believe — even how we vote — can be manipulated by the technology we use. Guests include journalist Carole Cadwalladr, consumer advocate Finn Myrstad, writer and marketing professor Scott Galloway, behavioral designer Nir Eyal, and computer graphics researcher Doug Roble.
Now Playing: Science for the People

#530 Why Aren't We Dead Yet?
We only notice our immune systems when they aren't working properly, or when they're under attack. How does our immune system understand what bits of us are us, and what bits are invading germs and viruses? How different are human immune systems from the immune systems of other creatures? And is the immune system so often the target of sketchy medical advice? Those questions and more, this week in our conversation with author Idan Ben-Barak about his book "Why Aren't We Dead Yet?: The Survivor’s Guide to the Immune System".